Seres Therapeutics, Inc. 4
4 · Seres Therapeutics, Inc. · Filed Apr 5, 2016
Insider Transaction Report
Form 4
COOK DAVID N
See Remarks
Transactions
- Sale
Common Stock
2016-04-04$28.00/sh−8,000$224,000→ 168,673 total - Sale
Common Stock
2016-04-01$26.90/sh−6,350$170,815→ 176,673 total - Sale
Common Stock
2016-04-01$25.74/sh−46,650$1,200,771→ 183,023 total
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $25.27 to $26.21. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $26.32 to $27.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.